Therefore, the aim of our study was to elucidate the mechanisms of PAH progression by evaluating the relationship between the cavin/caveolin system and BMP/Smad signaling and to investigate novel therapeutic targets of PAH. The gene discussed is CAVIN1; the disease is pulmonary arterial hypertension.